Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

[From Molecuar to Natural Medicine].

Allgaier HP, Arnold C, Baumert TF, Becker G, Geißler M, Hafkemeyer P, Harder J, Heim MH, Huber R, Kern WV, Mohr L, Moradpour D, Offensperger S, Offensperger WB, Spangenberg HC, Thimme R, Walter E, von Weizsäcker F.

Dtsch Med Wochenschr. 2018 Jan;143(1):40-45. doi: 10.1055/s-0043-123263. Epub 2018 Jan 9. German. No abstract available.

PMID:
29316584
2.

[Drug induced liver injury].

Spangenberg HC.

Dtsch Med Wochenschr. 2016 Nov;141(23):1688-1691. Epub 2016 Nov 17. Review. German.

PMID:
27855458
3.

Editorial: TIPSS in patients with cirrhosis and hepatocellular carcinoma - authors' reply.

Bettinger D, Knüppel E, Euringer W, Spangenberg HC, Rössle M, Thimme R, Schultheiß M.

Aliment Pharmacol Ther. 2015 Jan;41(2):231. doi: 10.1111/apt.13038. No abstract available.

4.

Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma.

Bettinger D, Knüppel E, Euringer W, Spangenberg HC, Rössle M, Thimme R, Schultheiß M.

Aliment Pharmacol Ther. 2015 Jan;41(1):126-36. doi: 10.1111/apt.12994. Epub 2014 Oct 20.

5.

Early mortality and long-term survival after abdominal surgery in patients with liver cirrhosis.

Neeff HP, Streule GC, Drognitz O, Tittelbach-Helmrich D, Spangenberg HC, Hopt UT, Makowiec F.

Surgery. 2014 Apr;155(4):623-32. doi: 10.1016/j.surg.2013.11.009. Epub 2013 Nov 22.

PMID:
24468037
6.

Influence of the transjugular intrahepatic portosystemic stent on firstline treatment of hepatocellular carcinoma.

Knüppel E, Bettinger D, Euringer W, Thimme R, Roessle M, Spangenberg HC, Schultheiβ M.

Hepatology. 2013 Dec;58(6):2211-2. doi: 10.1002/hep.26406. Epub 2013 Oct 21. No abstract available.

PMID:
23519917
7.

Selenium levels in patients with hepatitis C virus-related chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma: a pilot study.

Bettinger D, Schultheiss M, Hennecke N, Panther E, Knüppel E, Blum HE, Thimme R, Spangenberg HC.

Hepatology. 2013 Jun;57(6):2543-4. doi: 10.1002/hep.26142. No abstract available.

PMID:
23172787
8.

Diarrhea predicts a positive response to sorafenib in patients with advanced hepatocellular carcinoma.

Bettinger D, Schultheiss M, Knüppel E, Thimme R, Blum HE, Spangenberg HC.

Hepatology. 2012 Aug;56(2):789-90. doi: 10.1002/hep.25637. Epub 2012 Jul 6. No abstract available.

PMID:
22307848
9.

Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.

Kuhlmann JB, Euringer W, Spangenberg HC, Breidert M, Blum HE, Harder J, Fischer R.

Eur J Gastroenterol Hepatol. 2012 Apr;24(4):437-43. doi: 10.1097/MEG.0b013e3283502241.

PMID:
22261548
10.

[Hepatocellular carcinoma - from immunobiology to immunotherapy].

Flecken T, Schmidt N, Spangenberg HC, Thimme R.

Z Gastroenterol. 2012 Jan;50(1):47-56. doi: 10.1055/s-0031-1282002. Epub 2012 Jan 5. Review. German.

PMID:
22222798
11.

Clinical response to Auron Misheil Therapy in a man with advanced multifocal hepatocellular carcinoma: A case report.

Scheele JS, Harder J, Stankovic Z, Räpple D, Dorn A, Spangenberg HC, Blum HE.

J Med Case Rep. 2011 Sep 24;5:478. doi: 10.1186/1752-1947-5-478.

12.

[A rare cause of an indistinct liver lesion in an elderly woman].

Semmo N, Seuthe B, Er F, Spangenberg HC, Blum HE.

Dtsch Med Wochenschr. 2011 Jun;136(23):1251-4. doi: 10.1055/s-0031-1280545. Epub 2011 May 31. German.

PMID:
21630171
13.

Immunobiology of hepatocellular carcinoma.

Flecken T, Spangenberg HC, Thimme R.

Langenbecks Arch Surg. 2012 Jun;397(5):673-80. doi: 10.1007/s00423-011-0783-x. Epub 2011 Apr 9. Review.

PMID:
21479622
14.

[Inherited disorders of liver metabolism].

Büttner N, Spangenberg HC.

Ther Umsch. 2011 Apr;68(4):201-6. doi: 10.1024/0040-5930/a000151. Review. German.

PMID:
21452141
15.

Lack of ex vivo peripheral and intrahepatic α-fetoprotein-specific CD4+ responses in hepatocellular carcinoma.

Witkowski M, Spangenberg HC, Neumann-Haefelin C, Büttner N, Breous E, Kersting N, Drognitz O, Hopt UT, Blum HE, Semmo N, Thimme R.

Int J Cancer. 2011 Nov 1;129(9):2171-82. doi: 10.1002/ijc.25866. Epub 2011 Mar 25.

16.

Perioperative mortality after non-hepatic general surgery in patients with liver cirrhosis: an analysis of 138 operations in the 2000s using Child and MELD scores.

Neeff H, Mariaskin D, Spangenberg HC, Hopt UT, Makowiec F.

J Gastrointest Surg. 2011 Jan;15(1):1-11. doi: 10.1007/s11605-010-1366-9.

PMID:
21061184
17.

[Hepatology 2010].

Thimme R, Spangenberg HC, Blum HE.

Dtsch Med Wochenschr. 2010 Jun;135(25-26):1290-4. doi: 10.1055/s-0030-1255156. Epub 2010 Jun 9. Review. German. No abstract available.

PMID:
20535665
18.

Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154.

Mueller M, Spangenberg HC, Kersting N, Altay T, Blum HE, Klenerman P, Thimme R, Semmo N.

J Hepatol. 2010 Jun;52(6):800-11. doi: 10.1016/j.jhep.2009.12.038. Epub 2010 Mar 26.

PMID:
20416967
19.

Evolving treatments of virus-associated HCC: new targets and drugs.

Spangenberg HC, Thimme R, Blum HE.

Front Biosci (Schol Ed). 2010 Jan 1;2:439-53. Review.

PMID:
20036960
20.

Evolving therapies in the treatment of hepatocellular carcinoma.

Spangenberg HC, Thimme R, Blum HE.

Biologics. 2008 Sep;2(3):453-62.

21.

[Hepatology 2009].

Thimme R, Spangenberg HC, Blum HE.

Dtsch Med Wochenschr. 2009 Jun;134(25-26):1335-9. doi: 10.1055/s-0029-1225286. Epub 2009 Jun 10. German. No abstract available.

PMID:
19517326
22.

Targeted therapy for hepatocellular carcinoma.

Spangenberg HC, Thimme R, Blum HE.

Nat Rev Gastroenterol Hepatol. 2009 Jul;6(7):423-32. doi: 10.1038/nrgastro.2009.86. Epub 2009 Jun 2. Review.

PMID:
19488072
23.

Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment.

Erhardt A, Deterding K, Benhamou Y, Reiser M, Forns X, Pol S, Calleja JL, Ross S, Spangenberg HC, Garcia-Samaniego J, Fuchs M, Enríquez J, Wiegand J, Stern J, Wu K, Kukolj G, Marquis M, Beaulieu P, Nehmiz G, Steffgen J; BILB 1941 Study Group.

Antivir Ther. 2009;14(1):23-32.

PMID:
19320234
24.

Advances in prevention and diagnosis of hepatocellular carcinoma.

Spangenberg HC, Thimme R, Blum HE.

Expert Rev Gastroenterol Hepatol. 2008 Jun;2(3):425-33. doi: 10.1586/17474124.2.3.425. Review.

PMID:
19072390
25.

Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma.

Thimme R, Neagu M, Boettler T, Neumann-Haefelin C, Kersting N, Geissler M, Makowiec F, Obermaier R, Hopt UT, Blum HE, Spangenberg HC.

Hepatology. 2008 Dec;48(6):1821-33. doi: 10.1002/hep.22535.

PMID:
19003875
26.

[Resection or ablation in hepatocellular carcinoma: pro ablation].

Spangenberg HC.

Dtsch Med Wochenschr. 2008 Jul;133(30):1578. doi: 10.1055/s-2008-1081113. German. No abstract available.

PMID:
18642221
27.

[Hepatology 2008].

Thimme R, Spangenberg HC, Blum HE.

Dtsch Med Wochenschr. 2008 Jun;133(25-26):1366-9. doi: 10.1055/s-2008-1081082. Review. German. No abstract available.

PMID:
18553264
28.

Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain.

Bukh J, Thimme R, Meunier JC, Faulk K, Spangenberg HC, Chang KM, Satterfield W, Chisari FV, Purcell RH.

J Virol. 2008 Aug;82(16):8183-95. doi: 10.1128/JVI.00142-08. Epub 2008 Jun 11.

29.

Hypothyroidism in patients with hepatocellular carcinoma treated by transarterial chemoembolization.

Flohr F, Harder J, Seufert J, Blum HE, Spangenberg HC.

Hepatology. 2008 Jun;47(6):2144. doi: 10.1002/hep.22347. No abstract available.

PMID:
18459123
30.

Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection.

Neumann-Haefelin C, Timm J, Spangenberg HC, Wischniowski N, Nazarova N, Kersting N, Roggendorf M, Allen TM, Blum HE, Thimme R.

Hepatology. 2008 Jun;47(6):1824-36. doi: 10.1002/hep.22242.

PMID:
18454507
31.

[Chronic hepatitis B].

Thimme R, Spangenberg HC, Blum HE.

Dtsch Med Wochenschr. 2008 Jan;133(4):135-8. doi: 10.1055/s-2008-1017488. Review. German. No abstract available.

PMID:
18197589
32.

[Percutaneous liver biopsy].

Semmo N, Spangenberg HC, Blum HE.

Dtsch Med Wochenschr. 2007 Dec;132(49):2643-5. German. No abstract available.

PMID:
18050031
33.

Host and viral factors contributing to CD8+ T cell failure in hepatitis C virus infection.

Neumann-Haefelin C, Spangenberg HC, Blum HE, Thimme R.

World J Gastroenterol. 2007 Sep 28;13(36):4839-47. Review.

34.

[The hepatocellular carcinoma: alternative therapeutical strategies].

Spangenberg HC, Thimme R, Mohr L, Blum HE.

Zentralbl Chir. 2007 Aug;132(4):322-7. Review. German.

PMID:
17724635
35.

Hepatocellular carcinoma: an update.

Blum HE, Spangenberg HC.

Arch Iran Med. 2007 Jul;10(3):361-71. Review.

36.

[Hepatology 2007].

Thimme R, Spangenberg HC, Blum HE.

Dtsch Med Wochenschr. 2007 Jun 22;132(25-26):1392-5. Review. German. No abstract available.

PMID:
17570087
37.

In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells.

Sakai A, Takikawa S, Thimme R, Meunier JC, Spangenberg HC, Govindarajan S, Farci P, Emerson SU, Chisari FV, Purcell RH, Bukh J.

J Virol. 2007 Jul;81(13):7208-19. Epub 2007 Apr 4.

38.

[Regional therapy of liver tumors].

Spangenberg HC, Mohr L, Blum HE.

Internist (Berl). 2007 Jan;48(1):40-5. German.

PMID:
17160664
39.

Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.

Bengsch B, Spangenberg HC, Kersting N, Neumann-Haefelin C, Panther E, von Weizsäcker F, Blum HE, Pircher H, Thimme R.

J Virol. 2007 Jan;81(2):945-53. Epub 2006 Nov 1.

40.

Serum markers of hepatocellular carcinoma.

Spangenberg HC, Thimme R, Blum HE.

Semin Liver Dis. 2006 Nov;26(4):385-90. Review.

PMID:
17051452
41.

[Vasculitis and liver disease].

Spangenberg HC, Blum HE.

Praxis (Bern 1994). 2006 Oct 4;95(40):1557-62. Review. German.

PMID:
17048414
43.

Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.

Neumann-Haefelin C, McKiernan S, Ward S, Viazov S, Spangenberg HC, Killinger T, Baumert TF, Nazarova N, Sheridan I, Pybus O, von Weizsäcker F, Roggendorf M, Kelleher D, Klenerman P, Blum HE, Thimme R.

Hepatology. 2006 Mar;43(3):563-72.

PMID:
16496339
44.

[The patient as partner -- observations regarding a respectful relationship with sick people].

Rösler K, Thimme R, Spangenberg HC, Blum HE.

Dtsch Med Wochenschr. 2005 Dec 23;130(51-52):2937-9. German. No abstract available.

PMID:
16358174
45.

Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-alpha.

Jorns C, Holzinger D, Thimme R, Spangenberg HC, Weidmann M, Rasenack J, Blum HE, Haller O, Kochs G.

J Med Virol. 2006 Jan;78(1):74-82.

PMID:
16299717
46.

Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.

Spangenberg HC, Viazov S, Kersting N, Neumann-Haefelin C, McKinney D, Roggendorf M, von Weizsäcker F, Blum HE, Thimme R.

Hepatology. 2005 Oct;42(4):828-37.

PMID:
16175596
47.

T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

Boettler T, Spangenberg HC, Neumann-Haefelin C, Panther E, Urbani S, Ferrari C, Blum HE, von Weizsäcker F, Thimme R.

J Virol. 2005 Jun;79(12):7860-7.

48.

Hepatitis B or hepatitis C and human immunodeficiency virus infection.

Thimme R, Spangenberg HC, Blum HE.

J Hepatol. 2005;42 Suppl(1):S37-44. Epub 2005 Jan 28. Review. No abstract available.

PMID:
15777571
49.

[Hereditary liver diseases].

Spangenberg HC, Rösler K, Blum HE.

Ther Umsch. 2004 Aug;61(8):513-20. Review. German.

PMID:
15457968
50.

[Suppressor T-cells: immunologic regulator cells and clinical perspectives].

Neumann-Haefelin C, Spangenberg HC, Thimme R, Blum HE.

Dtsch Med Wochenschr. 2004 Jul 23;129(30):1627-30. Review. German.

PMID:
15257502

Supplemental Content

Loading ...
Support Center